Apo-Travoprost-Timop · DIN 02415305 · 0.5% & 0.004% · Oph Sol
Limited Use, Reason for Use code 310, 393 required; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health CanadaMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 310, 393 required; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada
Write on scriptone applicable Reason for Use code, 310 or 393 (criteria below); DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 310, 393
Reason for Use code 310
As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 393
For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Apo-Travoprost-Timop · DIN 02415305
Manufacturer: Apotex Inc.; listing date 2019-04-30
Health Canada: Marketed since 2020-03-03 · brand APO-TRAVOPROST-TIMOP PQ · ATC S01ED51 TIMOLOL, COMBINATIONS · form Solution · route Ophthalmic · ingredients TRAVOPROST 0.004 %/W/V, TIMOLOL (TIMOLOL MALEATE) 0.5 %/W/V · company Apotex inc · schedule Prescription
Apo-Travoprost-Timop: Formulary list price $8.84 per unit (the source does not state the unit; exact figure $8.8425). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02415305)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02415305).
DIN 02415305: Apo-Travoprost-Timop
Raw flags: dinStatus=E, sec12=Y, sec3=Y
Item: 523600116; group id 642; item number 1618; lccId 00198; manufacturer id APX
Source form: Oph Sol; strength: 0.5% & 0.004%
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; DIN status E, meaning unconfirmed
Source prices (unrounded): $8.8425; ministry $8.8425
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02415305
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89992
Interchangeable products
DuoTrav · DIN 02278251 · not recorded
Shortage status: not checked (no credentials)